Sanjay Shukla - Jul 1, 2022 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
/s/ Nancy E. Denyes, Attorney-in-Fact
Stock symbol
LIFE
Transactions as of
Jul 1, 2022
Transactions value $
$43,164
Form type
4
Date filed
7/6/2022, 05:02 PM
Previous filing
May 26, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $43.2K +15K +58.14% $2.88 40.8K Jul 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.86 to $2.89 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price